{"created":"2025-02-18T09:00:24.302653+00:00","id":2002984,"links":{},"metadata":{"_buckets":{"deposit":"b39b57a4-c8b7-4f81-bd1c-63b2ccaed6b4"},"_deposit":{"created_by":41,"id":"2002984","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"2002984"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02002984","sets":["1730444908512:1730444911147"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Sofosbuvir based regimen of antiviral therapy for patients with chronic hepatitis C virus infection  1) Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2  2) Real world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus related decompensated cirrhosis","subitem_title_language":"en"},{"subitem_title":"慢性C型肝炎ウイルス感染患者に対するソフォスブビルをベースとした抗ウイルス治療について　1）C型肝炎ウイルスジェノタイプ２型感染患者におけるソフォスブビル+リバビリン治療の有効性の予測因子および肝硬度の変化について　2）C型肝炎ウイルス関連非代償性肝硬変患者に対するソフォスブビル+ベルパタスビル治療の実臨床における有効性について","subitem_title_language":"ja"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"大屋, 一輝","creatorNameLang":"ja"},{"creatorName":"Oya, Kazuki","creatorNameLang":"en"}],"familyNames":[{"familyName":"大屋","familyNameLang":"ja"},{"familyName":"Oya","familyNameLang":"en"}],"givenNames":[{"givenName":"一輝","givenNameLang":"ja"},{"givenName":"Kazuki","givenNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"1) (c) 2018 Wiley Periodicals, Inc."},{"subitem_rights":"2) (c) 2020 The Japan Society of Hepatology"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"内容の要約","subitem_description_type":"Other"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617187087799":{"attribute_name":"Dissertation Number","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第8521号"}]},"item_1617187112279":{"attribute_name":"Degree Name","attribute_value_mlt":[{"subitem_degreename":"博士(医学)","subitem_degreename_language":"ja"},{"subitem_degreename":"Doctor of Philosophy in Medical Science","subitem_degreename_language":"en"}]},"item_1617187136212":{"attribute_name":"Date Granted","attribute_value_mlt":[{"subitem_dategranted":"2021-03-23"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"1) Ohya, K, Akuta, N, Suzuki, F, et al. Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2. J Med Virol. 2018; 90: 919-925"}]},{"subitem_relation_name":[{"subitem_relation_name_text":"2) Ohya, K., Imamura, M., Teraoka, Y., Morio, K., Fujino, H., Nakahara, T., Ono, A., Murakami, E., Kawaoka, T., Miki, D., Tsuge, M., Hiramatsu, A., Aikata, H., Hayes, C. N., Mori, N., Takaki, S., Tsuji, K., Aisaka, Y., Ishitobi, T., Katamura, Y., Kodama, H., Nabeshima, Y., Masaki, K., Honda, Y., Moriya, T., Kohno, H., Kohno, H., and Chayama, K. (2020) Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis. Hepatol Res, 50: 1234-1243"}]},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1002/jmv.25023","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1111/hepr.13555","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k8521_1.pdf","filesize":[{"value":"484.9 KB"}],"mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://hiroshima.repo.nii.ac.jp/record/2002984/files/k8521_1.pdf"},"version_id":"eaab8ee7-1dbd-4890-ae54-3e80ec09e598"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k8521_2.pdf","filesize":[{"value":"480.0 KB"}],"mimetype":"application/pdf","url":{"objectType":"abstract","url":"https://hiroshima.repo.nii.ac.jp/record/2002984/files/k8521_2.pdf"},"version_id":"581b170c-3992-4a72-8104-1249b4253b49"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k8521_4_1.pdf","filesize":[{"value":"539.9 KB"}],"mimetype":"application/pdf","url":{"objectType":"summary","url":"https://hiroshima.repo.nii.ac.jp/record/2002984/files/k8521_4_1.pdf"},"version_id":"6d482e58-2a1d-4466-b70f-be80dc4c77cf"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"k8521_4_2 .pdf","filesize":[{"value":"310.0 KB"}],"mimetype":"application/pdf","url":{"objectType":"summary","url":"https://hiroshima.repo.nii.ac.jp/record/2002984/files/k8521_4_2 .pdf"},"version_id":"a338e512-1174-4295-b21e-19b67d63ac26"}]},"item_1617944105607":{"attribute_name":"Degree Grantor","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"広島大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"15401","subitem_degreegrantor_identifier_scheme":"kakenhi"}]},{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"en","subitem_degreegrantor_name":"Hiroshima University"}]}]},"item_1732771732025":{"attribute_name":"旧ID","attribute_value":"51294"},"item_title":"Sofosbuvir based regimen of antiviral therapy for patients with chronic hepatitis C virus infection  1) Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2  2) Real world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus related decompensated cirrhosis","item_type_id":"40003","owner":"41","path":["1730444911147"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-03-18"},"publish_date":"2023-03-18","publish_status":"0","recid":"2002984","relation_version_is_last":true,"title":["Sofosbuvir based regimen of antiviral therapy for patients with chronic hepatitis C virus infection  1) Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2  2) Real world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus related decompensated cirrhosis"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2025-02-19T11:00:27.546806+00:00"}